{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Buena",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "87266",
      "recalling_firm": "Teligent Pharma, Inc.",
      "address_1": "105 Lincoln Avenue",
      "address_2": "N/A",
      "postal_code": "08310",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA Nationwide",
      "recall_number": "D-0340-2021",
      "product_description": "Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, Distributed by: McKesson Corporation dba Sky Packaging 4971 Southbridge Blvd., Suite 101 Memphis, TN 38141, NDC 63739-996-15",
      "product_quantity": "N/A",
      "reason_for_recall": "Failed Impurities/ Degradation Specifications -  OOS for know impurity Betamethasone 17- propionate.",
      "recall_initiation_date": "20210202",
      "center_classification_date": "20210423",
      "termination_date": "20240815",
      "report_date": "20210505",
      "code_info": "Lot #: 15644, Exp 5/2022",
      "more_code_info": ""
    }
  ]
}